Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Cited by (1,001)

Items 301–400 of 1,001

1. The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects
   Francesca Anna Cupaioli, Fabio Andrea Zucca, Cinzia Caporale, Klaus‐Peter Lesch, Luca Passamonti, Luigi Zecca · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
2. Screening for 22q11 deletions in a schizophrenia population
   Tadao Arinami, Taisuke Ohtsuki, K. Takase · 2001 · Schizophrenia Research
3. Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men
   Kristina Annerbrink, Lars Westberg, Staffan Nilsson · 2008 · Metabolism
4. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol‐O‐methyltransferase are associated with familial prostate carcinoma risk in a Japanese population
   Kazuhiro Suzuki, Haruki Nakazato, Hiroshi Matsui et al. · 2003 · Cancer
5. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia
   Herlina Y. Handoko, Dale R. Nyholt, Nicholas K. Hayward, Deborah A. Nertney, Dominique E. Hannah, Louisa C. E. Windus, Carmel McCormack, H J Smith, Cheryl Filippich, Michael R. James et al. · 2004 · Molecular Psychiatry
6. Molecular genetics and racial disparities of uterine leiomyomas
   Essam-Eldin R. Othman, Ayman A. Al-Hendy · 2008 · Best Practice & Research Clinical Obstetrics & Gynaecology
7. The current status of association studies in obsessive-compulsive disorder
   Hemmings, Sîan M.J., Stein, Dan J. · 2006 · Psychiatric Clinics of North America
8. Prefrontal cognitive systems in schizophrenia : Towards human genetic brain mechanisms
   Hao Yang Tan, Joseph H. Callicott, Daniel R. Weinberger · 2009 · Cognitive Neuropsychiatry
9. Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models
   James N. Samsom, A. Wong · 2015 · Frontiers in Psychiatry
10. Clinical Decision Making Regarding Leiomyomata: What We Need in the Next Millenium
    A.F. Haney · 2000 · Environmental Health Perspectives
11. Pharmacotherapy of Posttraumatic Cognitive Impairments
    David B. Arciniegas, Jonathan Silver · 2006 · Behavioural Neurology
12. The Role of the Catechol-O-Methyltransferase (COMT) Gene in Personality and Related Psychopathological Disorders
    Christian Montag, Magdalena Jurkiewicz, Martin Reuter · 2012 · CNS & Neurological Disorders - Drug Targets
13. Personality and emotion
    Rainer Reisenzein, Hannelore Weber · 2012 · Cambridge University Press eBooks
14. Estrogen Sulfation Genes, Hormone Replacement Therapy, and Endometrial Cancer Risk
    Timothy Richard Rebbeck, Andrea B. Troxel, Yiting Wang, Amy H. Walker, Saarene Panossian, Stephen Gallagher, Ekaterina G. Shatalova, Rebecca L. Blanchard, Greta R. Bunin, Angela M. DeMichele et al. · 2006 · JNCI Journal of the National Cancer Institute
15. Genetic and non‐genetic influences on the development of co‐occurring alcohol problem use and internalizing symptomatology in adolescence: a review
    Luca Saraceno, Marcus Robert Munafo, Jon Heron, Nick J. Craddock, Marianne B. M. van den Bree · 2009 · Addiction
16. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children
    Tony J. Simon, Joel Pearson Bish, Carrie E. Bearden, Lijun Ding, Samantha Ferrante, VY NGUYEN, James C. Gee, Donna M. McDonald‐McGinn, Elaine H. Zackai, Beverly S. Emanuel · 2005 · Development and Psychopathology
17. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation
    Mellissa M. C. DeMille, Judith R. Kidd, Valeria Ruggeri, Meg A. Palmatier, David A Goldman, Adekunle Odunsi, Friday Ebhodaghe Okonofua, Elena L. Grigorenko, Leslie Olmstead Schulz, Batsheva Bonné et al. · 2002 · Human Genetics
18. Getting the right drug into the right patient
    Andrew Marshall · 1997 · Nature Biotechnology
19. Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood
    Nemoda, Zsofia, Szekely, Anna, Sasvari-Szekely, Maria · 2011 · Neuroscience & Biobehavioral Reviews
20. The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults
    Stefan Ehrlich, Eric M. Morrow, Joshua L. Roffman, Stuart R. Wallace, Melissa Naylor, H. Jeremy Bockholt, Antonia P. Lundquist, Anastasia Yendiki, Beng‐Choon Ho, Tonya J.H. White et al. · 2009 · NeuroImage
21. Mouse Models of 22q11 Deletion Syndrome
    Richard E. Paylor, Elizabeth Lindsay · 2006 · Biological Psychiatry
22. Review: HPA‐axis activity in alcoholism: examples for a gene–environment interaction
    Clarke, Toni‐Kim, Treutlein, Jens, Zimmermann, Ulrich S., Kiefer, Falk, Skowronek, Markus H., Rietschel, Marcella, Mann, Karl, Schumann, Gunter · 2008 · Addiction Biology
23. Molecular Genetic Findings in Suicidal Behavior: What is Beyond the Serotonergic System?
    Dan Rujescu, Andreas Thalmeier, Hans‐Jürgen Möller, Thomas Bronisch, Ina Giegling · 2006 · Archives of Suicide Research
24. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment
    Patricio Molero, Felipe Ortuño, Marta Zalacaín, Ana Patiño‐García · 2007 · The Pharmacogenomics Journal
25. Opioid neuropeptide genotypes in relation to heroin abuse: Dopamine tone contributes to reversed mesolimbic proenkephalin expression
    Andrej Nikoshkov, Katarina Drakenberg, Xinyu Wang, Mónika Horváth, Éva Keller, Yasmin L. Hurd · 2008 · Proceedings of the National Academy of Sciences
26. Association Analysis of a Functional Catechol-O-Methyltransferase Gene Polymorphism in Schizophrenic Patients in Taiwan
    Ying‐Jay Liou, Shih‐Jen Tsai, Chen‐Jee Hong, Ying-Chieh Wang, I‐Ching Lai · 2001 · Neuropsychobiology
27. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype
    James Loughead, E. Paul Wileyto, Jeffrey N. Valdez, Paul M. Sanborn, Kun Tang, Andrew A. Strasser, Kosha Ruparel, Rubik Ray, Ruben C. Gur, Caryn E. Lerman · 2008 · Molecular Psychiatry
28. Prepulse inhibition of the startle reflex depends on the catecholO-methyltransferase Val158Met gene polymorphism
    Panos Roussos, Stella G. Giakoumaki, Maria Rogdaki, Stefanos Pavlakis, Sophia Frangou, Panos Bitsios · 2008 · Psychological Medicine
29. Genetic Factors in Catechol Estrogen Metabolism in Relation to the Risk of Endometrial Cancer
    Jennifer A. Doherty, Noel S. Weiss, Robert J. Freeman, Douglas A. Dightman, Perry J. Thornton, John R. Houck, Lynda F. Voigt, Mary Anne Rossing, Stephen M. Schwartz, Chu Chen · 2005 · Cancer Epidemiology Biomarkers & Prevention
30. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome
    Vandana Shashi, MS Keshavan, TD Howard, MN Berry, Monica J. Basehore, Kathryn E. Lewandowski, Thomas Richard Kwapil · 2006 · Clinical Genetics
31. Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia
    Tadao Arinami · 2006 · Journal of Human Genetics
32. Effect of COMT val158met genotype on cognition and personality
    Abigail J. Sheldrick, Axel Krug, Valentin Markov, Dirk Leube, Tanja Maria Michel, Klaus Zerres, Thomas Eggermann, Tilo T. J. Kircher · 2008 · European Psychiatry
33. COMT genotype and cognitive ability: A longitudinal aging study
    John M. Starr, Helen C Fox, Sarah E. Harris, Ian J. Deary, Lawrence J. Whalley · 2007 · Neuroscience Letters
34. Molecular genetics and antisocial behavior: Where do we stand?
    Caterina Iofrida, Sara Palumbo, Silvia Pellegrini · 2014 · Experimental Biology and Medicine
35. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5
    George Kirov, Ian Richard Jones, Fiona McCandless, Nick J. Craddock, M J Owen · 1999 · Molecular Psychiatry
36. Family Structure Instability, Genetic Sensitivity, and Child Well-Being
    Colter M. Mitchell, Sara McLanahan, John Hobcraft, Jeanne Brooks-gunn B, Irwin Garfinkel, Daniel A. Notterman · 2015 · American Journal of Sociology
37. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
    Francesco Benedetti, Cristina Colombo, Adele Pirovano, Elena Marino, Enrico Smeraldi · 2008 · Psychopharmacology
38. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia
    Alan R. Sanders, I Rusu, Jubao Duan, J E Vander Molen, Cuiping Hou, Sibylle G. Schwab, Dieter B. Wildenauer, Maria M. Martinez, Pablo V. Gejman · 2004 · Molecular Psychiatry
39. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response
    Mbemba Jabbi, Ido P. Kema, Gieta van der Pompe, Gerard J. te Meerman, Johan Ormel, Johan A. den Boer · 2007 · Psychiatric Genetics
40. Cancer Biology and Prevention in Diabetes
    Swayam Prakash Srivastava, Julie E. Goodwin · 2020 · Cells
41. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease
    Robert A. Sweet, Bernie Devlin, Bruce G. Pollock, Danielle L. Sukonick, Kari B. Kastango, Silviu‐Alin Bacanu, Kodavali V. Chowdari, Steven Trent DeKosky, Robert E. Ferrell · 2005 · Molecular Psychiatry
42. Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach
    T Wang, Petra E. Franke, Helge Neidt, Sven Cichon, Michael Knapp, Dirk Lichtermann, Wolfgang Maier, Peter Propping, Markus Maria Nöthen · 2000 · Molecular Psychiatry
43. Relationship between catechol‐O‐methyltransferase polymorphism and treatment‐resistant schizophrenia
    Toshiya Inada, Ataru Nakamura, Yoshimi Iijima · 2003 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
44. Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome
    Maude Schneider, Martial Van der Linden, Bronwyn Glaser, Eleonora Rizzi, Sophie P. Dahoun, Christine Hinard, Lucia Bartoloni, Stylianos E. Antonarakis, Martin Debbané, Stephan Eliez M. D · 2012 · Psychiatry Research
45. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells
    Fang Lu, Muhammad Zahid, MUHAMMAD KHALID SAEED, Ercole L. Cavalieri, Eleanor G. Rogan · 2007 · The Journal of Steroid Biochemistry and Molecular Biology
46. Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia
    Rael D. Strous, Nigel M. Bark, Margaret G. Woerner, Herbert M. Lachman · 1997 · Biological Psychiatry
47. Effect of Schizotypy on Cognitive Performance and Its Tuning by COMT val158 Met Genotype Variations in a Large Population of Young Men
    Smyrnis, Nikolaos, Avramopoulos, Dimitrios, Evdokimidis, Ioannis, Stefanis, Costas N., Tsekou, Hara, Stefanis, Nicholas C. · 2007 · Biological Psychiatry
48. COMT Val158Met moderation of stress-induced psychosis
    Nicholas C. Stefanis, Cécile Henquet, Dimitrios Avramopoulos, Nikolaos Smyrnis, Ioannis Evdokimidis, Inez Myin‐Germeys, Costas N. Stefanis, Jim van Os · 2007 · Psychological Medicine
49. Gender-Dependent Association of the Functional Catechol-O-Methyltransferase Val158Met Genotype with Sensation Seeking Personality Trait
    Undine Emmi Lang, Malck Bajbouj, Thomas Sander, Juergen Gallinat · 2007 · Neuropsychopharmacology
50. Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients
    Shih‐Jen Tsai, Yung‐Tian A. Gau, Chen‐Jee Hong, Ying‐Jay Liou, Younger W.‐Y. Yu, Tai‐Jui Chen · 2008 · Journal of Affective Disorders
51. Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine
    Francesco Benedetti, Sara Dallaspezia, Cristina Colombo, Cristina Lorenzi, Adele Pirovano, Enrico Smeraldi · 2010 · European Psychiatry
52. COMT genotype, gender and cognition in community-dwelling, older adults
    Ruth M. O'Hara, Elana Miller, Chun-ping Liao, Nate Way, Xiaoyan Lin, Joachim Franz Hallmayer · 2006 · Neuroscience Letters
53. Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders
    Annamaria Vallelunga, Raffaella Flaibani, Patrizia Formento‐Dojot · 2011 · Parkinsonism & Related Disorders
54. Putative role of the COMT gene polymorphism (Val158Met) on verbal working memory functioning in a healthy population
    Mari Aguilera, Neus Barrantes‐Vidal, Bárbara Arias, Jorge Moya, Helena Villa, Manuel I. Ibáñez, Marı́a A. Ruipérez, Generós Ortet, Lourdes Fañanás · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
55. Modifying Effect of COMT Gene Polymorphism and a Predictive Role for Proteomics Analysis in Children’s Intelligence in Endemic Fluorosis Area in Tianjin, China
    Shun Zhang, Xiaofei Zhang, Hongliang Liu, Weidong Qu, Zhi‐Zhong Guan, Qiang Zeng, Chunyang Jiang, Hui Yuan Gao, Cheng Zhang, Rongrong Lei et al. · 2015 · Toxicological Sciences
56. Genetic polymorphisms and risk of breast cancer.
    Steven Scott Coughlin, Margaret Piper · 1999 · PubMed
57. Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism
    Francesco Benedetti, Barbara Barbini, Alessandro Bernasconi, Mara Cigala Fulgosi, Sara Dallaspezia, Chiara Gavinelli, Clara Locatelli, Cristina Lorenzi, Adele Pirovano, Daniele Radaelli · 2009 · Journal of Affective Disorders
58. The interaction of early life experiences with COMT val158met affects anxiety sensitivity
    Christian Rainer Baumann, Benedikt Klauke, Heike Weber, Katharina Domschke, Peter Zwanzger, Paul Pauli, Jürgen Deckert, Andreas Reif · 2013 · Genes Brain & Behavior
59. Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3′ UTR polymorphism of the dopamine transporter gene
    Zsanett Tárnok, Zsolt Rónai, Judit Gervai, Éva Kereszturi, Júlia Gádoros, Mária Sasvári‐Székely, Zsófia Nemoda · 2007 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
60. Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways
    Áine T. Behan, Magdalena Hryniewiecka, Colm M. P. O’Tuathaigh, Anthony Kinsella, Mary D Cannon, Maria Karayiorgou, Joseph A. Gogos, John L. Waddington, David Cotter · 2012 · Neuropsychopharmacology
61. Animal Models of Psychosis: Current State and Future Directions
    Alexandra D. Forrest, Carlos A. Coto, Steven J. Siegel · 2014 · Current Behavioral Neuroscience Reports
62. A Meta-Analysis of the Val158Met COMT Polymorphism and Violent Behavior in Schizophrenia
    Jay P. Singh, Jan Volavka, Pál Czobor, Richard A. Van Dorn · 2012 · PLoS ONE
63. Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies
    O. Kebir, R. Joober · 2011 · European Archives of Psychiatry and Clinical Neuroscience
64. Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
    Huanjie Yang, Kristin R. Landis‐Piwowar, Tak Hang Chan, Q. Ping Dou · 2011 · Current Cancer Drug Targets
65. The association between sleep spindles and IQ in healthy school-age children
    Reut Gruber, Merrill S. Wise, Sonia Frenette, Bärbel Knaüper, Alice Boom, Laura Fontil, Julie Carrier · 2013 · International Journal of Psychophysiology
66. Imaging the genetics of executive function
    Ciara M. Greene, Wouter Braet, Katherine A. Johnson, Mark A. Bellgrove · 2007 · Biological Psychology
67. Association between COMT Val158Met and psychiatric disorders: A comprehensive meta‐analysis
    Steven J. Taylor · 2017 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
68. Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications
    Kazunari Yoshida, Daniel J. Müller · 2018 · Complex Psychiatry
69. Prefrontal Electrophysiologic “Noise” and Catechol-O-Methyltransferase Genotype in Schizophrenia
    Georg Winterer, Michael F. Egan, Bhaskar S. Kolachana, Terry E. Goldberg, Richard Coppola, Daniel R. Weinberger · 2006 · Biological Psychiatry
70. Childhood trauma and COMT genotype interact to increase hippocampal activation in resilient individuals
    van Rooij, Sanne J. H., Stevens, Jennifer S., Ely, Timothy D., Fani, Negar, Smith, Alicia K., Kerley, Kimberly A., Lori, Adriana, Ressler, Kerry J., Jovanovic, Tanja · 2016 · Frontiers in Psychiatry
71. Postpartum depression symptoms
    Erika Comasco, Sara M. Sylvén, Fotios C. Papadopoulos, Inger Sundström Poromaa, Lars Oreland, Alkistis Skalkidou · 2010 · Psychiatric Genetics
72. Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms
    Jiaojiao Li, Chunxiao Sun, Wenwen Cai, Jing Li, Barry P. Rosen, Jian Chen · 2021 · Mutation Research/Reviews in Mutation Research
73. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia
    JANUSZ K. RYBAKOWSKI, Alina Borkowska, Piotr M. Czerski, Paweł Kapelski, Monika Dmitrzak‐Węglarz, Joanna Hauser · 2005 · Journal of Neural Transmission
74. Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome
    Doron Gothelf, Amanda J. Law, Amos Frisch, Jingshan Chen, Omer Zarchi, Elena Michaelovsky, Renee F. Ren‐Patterson, Barbara K. Lipska, Miri Carmel, Bhaskar S. Kolachana et al. · 2013 · Biological Psychiatry
75. Influence of Single Nucleotide Polymorphisms in COMT, MAO-A and BDNF Genes on Dyskinesias and Levodopa Use in Parkinson's Disease
    Perdita Cheshire, Kelly Bertram, Helen Ling · 2013 · Neurodegenerative Diseases
76. Hormonal and Genetic Influences on Processing Reward and Social Information
    Xavier Caldú, Jean‐Claude Dreher · 2007 · Annals of the New York Academy of Sciences
77. Association of COMT Val108/158Met genotype with smoking cessation
    Munafò, Marcus R., Johnstone, Elaine C., Guo, Boliang, Murphy, Michael F.G., Aveyard, Paul · 2008 · Pharmacogenetics and Genomics
78. Sex steroid–related candidate genes in psychiatric disorders
    Lars Westberg, Elias Eriksson · 2008 · Journal of Psychiatry and Neuroscience
79. Role of COMT in ADHD: a Systematic Meta-Analysis
    Hongjuan Sun, Fang-fen Yuan, Xuemei Shen, Guang-Lian Xiong, Jing Wu · 2014 · Molecular Neurobiology
80. Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test
    Julian Lim, Richard P. Ebstein, Chun‐Yu Tse, Mikhail V. Monakhov, Poh San Lai, David F. Dinges, Kenneth Kwok · 2012 · PLoS ONE
81. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome
    Doron Gothelf, Fumiko Hoeft, Takefumi Ueno, Lisa Sugiura, Agatha D. Lee, Paul M. Thompson, Allan L. Reiss · 2010 · Journal of Psychiatric Research
82. Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation
    Katharina Schmack, Florian Schlagenhauf, Philipp Sterzer, Jana Wrase, Anne Beck, Theresa Dembler, Peter Kalus, Imke Puls, Thomas Sander, Andreas Heinz et al. · 2008 · NeuroImage
83. COMT genotype affects prefrontal white matter pathways in children and adolescents
    Moriah E. Thomason, Robert F. Dougherty, Natalie L. Colich, Lee Michael Perry, Elena I. Rykhlevskaia, Hugo M.C. Louro, Joachim Franz Hallmayer, Christian E. Waugh, Roland Bammer, Gary H. Glover et al. · 2010 · NeuroImage
84. Pharmacogenetics of antidepressant response
    Robert Keers, Katherine Jean Aitchison · 2010 · Expert Review of Neurotherapeutics
85. Brain white matter structure and COMT gene are linked to second-language learning in adults
    Ping Chao Mamiya, Todd L. Richards, Bradley P. Coe, Evan E. Eichler, Patricia K. Kuhl · 2016 · Proceedings of the National Academy of Sciences
86. Pharmacogenetics of antipsychotic-induced side effects
    Todd Lencz, Anil K. Malhotra · 2009 · Dialogues in Clinical Neuroscience
87. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility
    Monica McGrath · 2003 · Carcinogenesis
88. Linkage and association studies of schizophrenia
    Peter McGuffin, Kopal Tandon, Alejandro Corsico · 2003 · Current Psychiatry Reports
89. Association of <i>COMT</i> Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial
    Johnstone, Elaine C., Elliot, Katherine M., David, Sean P., Murphy, Michael F.G., Walton, Robert T., Munafò, Marcus R. · 2007 · Cancer Epidemiology, Biomarkers &amp; Prevention
90. Pharmacogenomics: Catechol-O-methyltransferase to thiopurine S-methyltransferase
    Weinshilboum, Richard M. · 2006 · Cellular and Molecular Neurobiology
91. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population
    Pilar Armero, Clemente Muriel, Juan Santos, F. J. Sánchez-Montero, Raquel E. Rodróguez, Rogelio González‐Sarmiento · 2004 · European Journal of Pain
92. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility
    Berna Tander, Sezgin Ozgur Gunes, Ömer Böke, Gamze Alaylı, Nurten Kara, Hasan Bağcı, Ferhan Cantürk · 2008 · Rheumatology International
93. Polymorphisms in Dopamine System Genes Are Associated With Individual Differences in Attention in Infancy
    K. Holmboe, Z. Nemoda, R. M. Pasco Fearon, G. Csibra, M. Sasvári-Székely, Mark H. Johnson · 2010 · Developmental Psychology
94. Variations in the catechol O-methyltransferase polymorphism and prefrontally guided behaviors in adolescents
    Wahlstrom, Dustin, White, Tonya, Hooper, Catalina J., Vrshek-Schallhorn, Suzanne, Oetting, William S., Brott, Marcia J., Luciana, Monica · 2007 · Biological Psychiatry
95. Cross-species assessments of motor and exploratory behavior related to bipolar disorder
    Brook L. Henry, Arpi Minassian, Jared W. Young, Martin P. Paulus, Mark A. Geyer, William Perry · 2010 · Neuroscience & Biobehavioral Reviews
96. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis
    Eric Huang, Clement C.H. Zai, Amanda J. Lisoway, Małgorzata Maciukiewicz, Daniel Felsky, Arun Kumar Tiwari, Jeffrey R. Bishop, Masashi Ikeda, Patricio Molero, Felipe Ortuño et al. · 2016 · The International Journal of Neuropsychopharmacology
97. Catechol-O -methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis
    Hasan Herken, Mehmet Emin Erdal · 2001 · Psychiatric Genetics
98. The Catechol-O-Methyltransferase (COMT) val158met Polymorphism Affects Brain Responses to Repeated Painful Stimuli
    Marco L. Loggia, Karin Birgitta Jensen, Randy L. Gollub, Ajay D. Wasan, Robert Randolph Edwards, Jian Kong · 2011 · PLoS ONE
99. An Overview of the Association between Schizotypy and Dopamine
    Mohr, Christine, Ettinger, Ulrich · 2014 · Frontiers in Psychiatry
100. PhRMA White Paper on ADME Pharmacogenomics
     J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca L. Blanchard, Martin Otto Behm, Nadine Cohen, Timi I. Edeki, Monique A. Franc, Kathleen M. Hillgren, Keith J. Johnson et al. · 2008 · The Journal of Clinical Pharmacology